Navigation Links
WMIS Supports Experts, Commits to Resolve Beta Amyloid Issues with CMS
Date:2/7/2013

Washington DC (PRWEB) February 07, 2013

On January 30th, 2013 CMS (Centers for Medicare & Medicaid Services) held the MEDCAC (Medicare Evidence Development & Coverage Advisory Committee) meeting to review the available evidence and hear public testimony on the use of beta amyloid PET imaging for the management of dementia and neurodegenerative disease. At the conclusion of the presentations and discussion, the panel voted ‘low to intermediate’ confidence in evidence supporting the PET imaging of brain beta amyloid to change health outcomes (improved, equivalent or worsened) in patients who display early symptoms or signs of cognitive dysfunction.
Based upon the scientific evidence acquired over the years, WMIS supports the position that PET Imaging does change the health outcomes. This position is similar to the testimony of several experts who presented during the meeting. “We stay firm in our belief that PET imaging can truly help improve health outcomes in patients and we support the testimony of the medical experts. We are committed to work with CMS to resolve any outstanding issues about beta amyloid imaging.” said Kim Pierce, Executive Director of WMIS.

WMIS is the molecular imaging sector’s largest source of information and data on reimbursement since it manages the NOPR. The National Oncologic PET Registry (NOPR) is a collaboration of the American College of Radiology Imaging Network (ACRIN), the American College of Radiology (ACR), and the World Molecular Imaging Society (WMIS), to ensure access to Medicare reimbursement for certain types of positron emission tomography (PET) scans.

The testimony of medical experts clearly demonstrated that significant evidence already exists. “It is important to recognize that the panel is concerned about insufficient evidence and is not questioning the fundamental premise of the diagnostic test. We invite CMS to work with the industry and molecular imaging societies to receive further clarification. We firmly believe that the opinions of the well-recognized experts in the field should be given priority to determine the future of this FDA approved powerful innovation.” Kim Pierce added.

About WMIS
WMIS is an academic and professional society for Molecular Imaging. From leading projects such as PET awareness campaigns and registry management on the clinical side to developing powerful preclinical models and training programs, WMIS is active across the entire spectrum of Molecular Imaging. WMIS is the world's most innovative and leading society in molecular imaging and molecular medicine. With the rise of the molecular imaging industry and the associated research, WMIS is the only organization that is connecting all the dots in the industry and is working to bring all stakeholders together by Smashing the Silos and Leading Innovation Convergence in molecular medicine through imaging; both for practitioners and researchers, who are defining the future of molecular imaging, WMIS enhances the potential and applications of innovation. http://www.wmis.org

Read the full story at http://www.prweb.com/releases/2013/2/prweb10402159.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
2. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
3. MDA Supports Development of Dissociative Glucocorticoid for DMD
4. InVigor® Canola Supports the Michigan-Whitman Fire Department with More for Everyone Award
5. InVigor® Canola Supports Cando Youth Hockey with More for Everyone Award
6. InVigor® Canola Supports Langdon Day Care Center with More for Everyone Award
7. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
8. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
9. CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimers Imaging Market Space
10. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
11. Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... The global chronic kidney disease ... by Transparency Market Research (TMR). The top four players, ... Inc., accounted for a share of only 41.4% in ... market are focusing aggressively on mergers, acquisitions, and strategic ... to lead to market consolidation in the next few ...
(Date:3/22/2017)... Pa. , March 22, 2017 /PRNewswire/ ... global independent provider of product and service ... today that it has acquired EPL Archives, ... supports customers across the entire regulated product ... archive sample, document storage and ancillary services. ...
(Date:3/22/2017)... ... 21, 2017 , ... Benchworks CEO Thad L. Bench Sr. will ... March 23-24 in San Diego. The event is a gathering of executive leadership from ... Vice President Christian Meyer will also participate in the forum. Participants will discuss the ...
(Date:3/22/2017)... CARDIFF, UK (PRWEB) , ... March 21, 2017 , ... ... and tissue oxygenation, is being explored as a way to track the brain’s response ... on tonic pain activation by cold pressor test ,” published today in the ...
Breaking Biology Technology:
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):